GENE ONLINE|News &
Opinion
Blog

Biohaven
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
LATEST
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
EVENT
Scroll to Top